CalcMyPeptide
Clinical / PharmaceuticalAlso known as: Cosyntropin, Synacthen, ACTH 1-24, Tetracosactrin

Tetracosactide

Synthetic 24-amino-acid fragment of ACTH — FDA-approved as a diagnostic agent for adrenal insufficiency (Synacthen/cosyntropin stimulation test).

Half-Life
0.25 hours
Dose Range
250 mcg IV/IM (diagnostic)
Frequency
Single dose (ACTH stimulation test)
Vial Sizes
N/A (oral)

🔬 Mechanism of Action

Tetracosactide (cosyntropin) is a synthetic 24-amino-acid peptide corresponding to the first 24 residues of endogenous 39-amino-acid ACTH. These N-terminal 24 residues contain the full biological activity of ACTH. Upon IV or IM administration, it binds the melanocortin-2 receptor (MC2R) in the zona fasciculata of the adrenal cortex, activating adenylyl cyclase → cAMP → PKA pathway. This triggers acute steroidogenesis: cholesterol transport into mitochondria via StAR protein, followed by cortisol synthesis within 30-60 minutes. The standard 250 mcg dose produces supraphysiologic ACTH stimulation. A low-dose 1 mcg test may be more sensitive for detecting partial adrenal insufficiency.

Source: PMID: 6765449

📜Background & History

Tetracosactide (cosyntropin/Synacthen) is an essential diagnostic tool in endocrinology. The ACTH stimulation test has been the gold standard for diagnosing adrenal insufficiency for over 50 years. The short Synacthen test takes only 1 hour and can be performed in outpatient settings. Depot formulations (Synacthen Depot) have also been used therapeutically for infantile spasms and inflammatory conditions in various countries.

🎯 Research Use Cases

  • Adrenal insufficiency diagnosis
  • ACTH stimulation test
  • Infantile spasms (depot form)
  • Therapeutic use in inflammatory conditions

💉 Dosing Protocol

Typical Dose250 mcg IV/IM (diagnostic)
FrequencySingle dose (ACTH stimulation test)
Half-Life0.25 hours

⚠️Safety & Considerations

Generally well-tolerated as a single diagnostic dose. Rare allergic reactions possible. Depot formulations (Synacthen Depot) used therapeutically carry risks of adrenal suppression on withdrawal. Contraindicated in patients with adrenal carcinoma.

Interactions & Contraindications

Exogenous corticosteroids will blunt the cortisol response and should be withheld before testing. Dexamethasone does not cross-react with cortisol assays.

📊 Dosing Quick Reference

Tetracosactide— Dosing Guide
Dose Range
250 mcg IV/IM (diagnostic)
Half-Life
0.25 hours
Frequency
Single dose (ACTH stimulation test)
Route
Oral
Clinical / Pharmaceuticalcalcmypeptide.com

Frequently Asked Questions

What is the cosyntropin stimulation test?
The gold standard for diagnosing adrenal insufficiency: 250 mcg cosyntropin is given IV/IM, and serum cortisol is measured at 0, 30, and 60 minutes. A peak cortisol ≥18 mcg/dL rules out primary adrenal insufficiency.